Approval · Notice of Compliance 2941 · 1998
ZOLADEX: Notice of Compliance 2941
Issued April 8, 1998
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 2941
- Date
- April 8, 1998
- Company
- Zeneca Pharma Inc.Mississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New indication: for the pallative treatment of advanced breast cancer in pre- and perimenopausal women whose tumor contains estrogen and/or progesterone receptors
- Therapeutic class
- Luteinizing hormone - releasing hormone analog
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ZOLADEX | Not yet assigned | — |
Medicinal ingredients
- GOSERELIN ACETATE 3.6 MG per ML